
PMV Pharmaceuticals, Inc. (PMVP)
Last updated: 2026-10-21 19:43:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
PMV Pharmaceuticals, Inc. (PMVP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.38, with a market capitalization of $67.09M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.02 to $1.91. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$67.09M | |
$1.37 | |
$63.22 | |
$0.81 | |
$1.39 | |
57.94K | |
676.93K | |
-- | |
$1.91 | |
$1.02 | |
-- | |
-- |
PMV Pharmaceuticals, Inc. (PMVP) Stock Price Today
PMV Pharmaceuticals, Inc. (PMVP) is currently trading at $1.38 as of 2026-10-21 19:26:34, down 1.08% ($0.01) from the previous close of $1.39
During today's regular trading session, PMVP has traded between $0.81 and $63.22, with a trading volume of 57.94K shares. The current price is near the lower end of today's range.
PMV Pharmaceuticals, Inc. (PMVP) 7-Day Stock Price Change
Over the past seven days, PMV Pharmaceuticals, Inc. (PMVP) moved from $1.41 to $1.38, representing a decline of 2.48% ($0.03).
The stock traded between $1.20 and $1.55 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 392.15 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
PMVP 52-Week Price Position
Position in Range: 39.9%
PMVP is currently trading at $1.38, placing it 39.9% of the way from its 52-week low of $1.02 to its 52-week high of $1.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is PMV Pharmaceuticals, Inc. (PMVP)?
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
PMV Pharmaceuticals, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 54 |
| Exchange | NASDAQ |
| Company Website |
How to Buy PMV Pharmaceuticals, Inc. (PMVP) Stock on MEXC
Eligible investors can buy real shares of PMV Pharmaceuticals, Inc. (PMVP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is PMV Pharmaceuticals, Inc. (PMVP) stock price today?
2.Is PMVP stock going up or down today?
3.What is PMVP pre-market price?
4.What is PMVP after-hours price?
5.Is PMVP stock trading now?
6.Where does PMVP sit relative to its 52-week high and low?
7.What sector is PMV Pharmaceuticals, Inc. in?
8.What is PMV Pharmaceuticals, Inc.'s market capitalization and where is it listed?
9.How is PMVP valued in terms of P/E ratio and EPS?
10.Does PMV Pharmaceuticals, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PMVP Stock Calculator
Estimate the value between PMVP shares and USD.
PMVP Shares to USD
1.00 PMVP shares = 1.375 USD
Calculations are estimates based on the latest available price and are for reference only.


